The COVID-19 pandemic is an ongoing, unprecedented global health challenge, and bioMérieux is proud to be part of the global response.
It has developed three of the first commercially available diagnostic tests for SARS-CoV-2, along
with additional critical tests for COVID-19 patient management.
The SARS-CoV-2 R-GENE assay is a real-time PCR kit for the detection of SARS-CoV-2. The new BIOFIRE FILMARRAY Respiratory 2.1 Plus Panel enables rapid and accurate automated detection of pathogens behind respiratory infections. It tests for 19 viruses including SARS-CoV-2, and four bacteria that cause respiratory tract infections in 45 minutes.
Individual VIDAS SARS-CoV-2 IgG and IgM antibody assays complement the company’s PCR solutions.
Every COVID-19 patient comes with a unique profile and experiences the disease differently. Patient management means asking the right questions, finding the right answers and providing
appropriate care on the entire length of the patient pathway.
www.biomerieux.com